Distress andneoangiogenesis in ovarian cancer patients

Distress andneoangiogenesis in ovarian cancer patients

Background. Previous pre-clinical and clinical trials showed that distress experienced by cancer patients can activate the sympathetic nervous system, resulting in the elevation of the level of catecholamines in tumor tissue. catecholamines activate tumor neoangiogenesis via binding to the adrenergi...

Full description

Bibliographic Details
Main Authors:	G. P. Guens, I. N. Oleynikova, N. A. Sirota, N. I. Moiseeva, V. E. Shikina, V. V. Kirkin
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2019-04-01
Series:	Сибирский онкологический журнал
Subjects:	ovarian cancer distress neoangiogenesis vascular endothelial growth factor a psycho-oncology quality of life
Online Access:	https://www.siboncoj.ru/jour/article/view/1010

Similar Items

Elevation of vascular endothelial growth factor and distress in ovarian cancer patients: are they correlated? The pilot trial
by: G. P. Guens, et al.
Published: (2016-06-01)

Resilience as a Factor Influencing Psychological Distress Experience in Patients with Neuro-Oncological Disease
by: Jan Ilgen, et al.
Published: (2022-12-01)

Screening for Distress in Oncological Patients: The Revised Version of the Psychological Distress Inventory (PDI-R)
by: Alessandro Alberto Rossi, et al.
Published: (2022-05-01)

Neoangiogenesis - forming an effective network of blood vessels as a critical determinant of tumor development
by: Grzegorz Wróbel, et al.
Published: (2017-12-01)

Distress and health-related quality of life in post-treatment nasopharyngeal carcinoma patients: a two-centre cross-sectional study
by: Mohamed Iliyas Sultan Abdul Kader, et al.
Published: (2024-12-01)

Psychosocial Distress in Women With Breast Cancer and Their Partners and Its Impact on Supportive Care Needs in Partners
by: Ute Goerling, et al.
Published: (2020-09-01)

Oncology distress screening within predominately Black Veterans: Outcomes on supportive care utilization, hospitalizations, and mortality
by: Desiree R. Azizoddin, et al.
Published: (2023-04-01)

Psycho-oncological burden in patients with brain metastases undergoing neurological surgery
by: Tommaso Araceli, et al.
Published: (2024-11-01)

Comparing the experiences of cancer survivors living with sleep disturbances between differing levels of psychological distress: a qualitative study
by: Julia Chan, et al.
Published: (2024-12-01)

Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014-08-01)

Impact of COVID-19 Epidemic on Psycho-Oncological Distress in Neuro-Oncological Patients
by: Franziska Staub-Bartelt, et al.
Published: (2022-12-01)

Termômetro de Distress: validação de um instrumento breve para avaliação diagnóstica de pacientes oncológicos Distress Thermometer: validation of a brief screening instrument to detect distress in oncology patients
by: Cristiane Sant'Anna Decat, et al.
Published: (2009-12-01)

Increased Distress in Neurooncological Patients, a Monocentric Longitudinal Study: When to Screen Which Patient?
by: Franziska Staub-Bartelt, et al.
Published: (2024-09-01)

A short screening tool identifying systemic barriers to distress screening in cancer care
by: Felice Simnacher, et al.
Published: (2023-08-01)

Predictive Factors Associated with Declining Psycho-Oncological Support in Patients with Cancer
by: Karoline Hecht, et al.
Published: (2023-11-01)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
by: Marzieh Agha Hosseini, et al.
Published: (2011-09-01)

Prognostic Role of Vascular Endothelial Growth Factor and Correlation with Oxidative Stress Markers in Locally Advanced and Metastatic Ovarian Cancer Patients
by: Oana Gabriela Trifanescu, et al.
Published: (2023-01-01)

The Arabic Hospital Anxiety and Depression Scale: validation in a sample of Lebanese patients with cancer
by: Nour Ibrahim, et al.
Published: (2023-10-01)

Posttraumatic stress disorder in patients with ovarian cancer
by: G. P. Gens, et al.
Published: (2014-12-01)

Confirmatory validation of a brief patient-reported outcome measure assessing psychological distress in caregivers of malignant mesothelioma patients: the Mesothelioma Psychological Distress Tool–Caregivers
by: Antonella Granieri, et al.
Published: (2024-10-01)

EVIDENCE-BASED RELATIONSHIP BETWEEN THE LEVELS OF IL-6, VECF, sFas, FasL AND ENDOSTATIN IN PATIENTS WITH OVARIAN NEOPLASMS
by: N. Ye. Kushlinsky, et al.
Published: (2014-09-01)

Psychosocial approach in clinical oncology. The history and progress
by: Holland J.C., et al.
Published: (2014-01-01)

Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial
by: Qianrong Qi, et al.
Published: (2023-12-01)

Psycho-oncology as part of holistic treatment of cancer patients
by: Andreja C. Škufca Smrdel, et al.
Published: (2024-12-01)

“Double whammy”: a rapid review of rural vs urban psychosocial cancer experiences and telehealth service in five countries during the COVID-19 pandemic
by: Marisa Barnes, et al.
Published: (2022-11-01)

Proof of concept: Predicting distress in cancer patients using back propagation neural network (BPNN)
by: Schulze Jan Ben, et al.
Published: (2023-08-01)

Expression of vascular endothelial factor protein in the tumor tissues of patients with Stages I-II ovarian cancer
by: V. L. Karapetyan, et al.
Published: (2014-08-01)

Psychological distress in biliary tract malignancy patients: influencing factors and development of a predictive nomogram model
by: Zhennan Gou, et al.
Published: (2024-12-01)

Disparities and barriers in the assessment of psychological distress, access to and use of psycho-oncological support in Europe: current perspectives
by: Veronica Coppini, et al.
Published: (2023-09-01)

Prevalence of mental disorders, psychosocial distress, and perceived need for psychosocial support in cancer patients and their relatives stratified by biopsychosocial factors: rationale, study design, and methods of a prospective multi-center observational cohort study (LUPE study)
by: Anja Mehnert-Theuerkauf, et al.
Published: (2023-04-01)

Erratum: Prevalence of mental disorders, psychosocial distress, and perceived need for psychosocial support in cancer patients and their relatives stratified by biopsychosocial factors: rationale, study design, and methods of a prospective multi-center observational cohort study (LUPE study)
by: Frontiers Production Office
Published: (2024-05-01)

Reading Wishes from the Lips: Cancer Patients’ Need for Psycho-Oncological Support during Inpatient and Outpatient Treatment
by: Jan Ben Schulze, et al.
Published: (2022-10-01)

Aptamers Versus Vascular Endothelial Growth Factor (VEGF): A New Battle against Ovarian Cancer
by: Yachana Mishra, et al.
Published: (2023-06-01)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
by: Fiedler Klaus, et al.
Published: (2012-04-01)

Nintedanib Treatment After Ovulation is an Effective Therapeutic Strategy for the Alleviation of Ovarian Hyperstimulation Syndrome (OHSS) in a Mouse Model
by: Jiang S, et al.
Published: (2022-02-01)

Understanding the Male Perspective: Evaluating Quality of Life and Psychological Distress in Serbian Men Undergoing Infertility Treatment
by: Bojan Čegar, et al.
Published: (2023-09-01)

Diagnostic value of placental growth factor in patients with coronary heart disease
by: M. V. Tulikov, et al.
Published: (2014-07-01)

Diagnostic value of placental growth factor in patients with coronary heart disease
by: M. V. Tulikov, et al.
Published: (2014-07-01)

Finding My Way-Advanced: can a web-based psychosocial intervention improve the mental quality of life for women with metastatic breast cancer vs attention-control? Study protocol of a randomised controlled trial
by: Lisa Beatty, et al.
Published: (2022-12-01)

Clinical case of ovarian cancer during pregnancy
by: Y E Dobrokhotova, et al.
Published: (2016-04-01)